Intermountain Healthcare launches long-term Precise study to collect genomic data

Researchers at Salt Lake City-based Intermountain Healthcare will collect fresh-tissue and blood samples from across the health system under a new long-term prospective study dubbed "Precise."

The researchers will recruit and enroll Intermountain Healthcare patients into the study to create a biobank. The biobank — which will include genomic data from Precise and clinical outcomes data — will serve as a research resource for future precision medicine projects.

Researchers will complete tissue analyses at Intermountain Healthcare's high-throughput sequencing facility in St. George, Utah.

"The multi-disciplinary nature and prospective design of Precise will be a challenge and require a tremendous amount of teamwork, but in the end, the pragmatic results will advance our knowledge regarding precision health and medicine initiatives," said Tyler Barker, PhD, senior research scientist at Intermountain Healthcare and principle Investigator for the Precise study.

More articles on data analytics & precision medicine:
St. Jude launches public pediatric cancer genomics platform on the cloud
UCSF Health to apply predictive analytics to medical equipment maintenance
How DNA sequencing has improved public health since the 2000s

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers